ClaripulseClaripulse
MAUDE LookupResourcesBlog
LoginGet Early Access
ClaripulseClaripulse

Product

MAUDE LookupDashboard

Guides

FDA MAUDE DatabasePost-Market SurveillanceSignal Detection

Learn

BlogResourcesWhy Claripulse?

Legal

Privacy PolicyTerms of Service

This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified — do not attempt re-identification. © 2026 Claripulse.

Back to Cardiac Rhythm Management
MAUDE LookupCardiac Rhythm ManagementRESONATE HF CRT-D

RESONATE HF CRT-D Adverse Events: FDA MAUDE Data

BOSTON SCIENTIFIC CORPORATION · CRT-Defibrillator (CRT-D) · First cleared May 2002

Total Reports

473

Reports (30d)

29

Active Signals

2

Open Recalls

1

Monthly Report Volume
Event Type Breakdown

What the reports describe · Claripulse analysis

Most commonly reported problems

1

Noise and Oversensing on Atrial Channel

defibrillator crt, crt, effects, service, therapy defibrillator

8

reports

2

CRT Revision Due to Infection

crt, crt revision, infection additional, reported crt, revision infection

8

reports

3

Inappropriate Therapy Delivered for Atrial Rhythm

crt, remains service, therapy, tachycardia, delivered

8

reports

4

CRT Revision for Infection

crt revision, infection additional, reported crt, revision infection, crt explanted

6

reports

5

Difficulty Interrogating CRT Device

resynchronization, defibrillator crt, crt, resynchronization therapy, therapy defibrillator

5

reports

6

Farfield Oversensing Leading to Atrial Response

defibrillator crt, crt, remains service, effects, therapy defibrillator

5

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Detection

Active safety signals

Disproportionate reportinghighIncreasing trendmedium

Regulatory

FDA recalls for this device

Class II

Jul 7, 2022 · Open, Classified

There is potential for unanticipated software anomalies to occur when using the Model 2868 Application loaded on the 3120 ZOOM LATITUTDE programmer when communicating with certain Boston Scientific transvenous defibrillators.

Evidence

Related research

Usefulness of Multisite Ventricular Pacing in Nonresponders to Cardiac Resynchronization Therapy

Samir Saba, et al. · The American Journal of Cardiology · 2021

Prediction of Heart Failure Events With the HeartLogic Algorithm: Real-World Validation

Jagmeet Singh, et al. · Journal of Cardiac Failure · 2023

Comparative Diagnostic Efficacy of HeartLogic and TriageHF Algorithms in Remote Monitoring of Heart Failure: A Cohort Study

David Ledesma Oloriz, et al. · Journal of Cardiovascular Development and Disease · 2025

Implantable Cardioverter Defibrillator Multisensor Monitoring during Home Confinement Caused by the COVID-19 Pandemic

Matteo Ziacchi, et al. · Biology · 2022

Citations indexed from PubMed.

Keep exploring

Related devices in CRM

CAPSUREFIX Novus

MEDTRONIC, INC. · 43,528 reports

→

EMBLEM S-ICD

BOSTON SCIENTIFIC CORPORATION · 36,855 reports

→

Sprint Quattro Secure S MRI SureScan

MEDTRONIC, INC. · 36,335 reports

→

CapSureFix Novus MRI SureScan

MEDTRONIC, INC. · 27,017 reports

→

Durata

ABBOTT (ST. JUDE MEDICAL) · 19,619 reports

→

Quadra Assura MP

ABBOTT (ST. JUDE MEDICAL) · 10,450 reports

→

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 2 active signals detected right now.

Get Early Access

Understanding this data

What FDA MAUDE data does and does not tell you

How these reports are filed, why raw counts mislead, and the limits to know before drawing conclusions.

→

How a safety signal is detected

What the "Active Signals" count above means and the methods that separate a real signal from noise.

→
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.